Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of CD5024 (ivermectin) cream vs vehicle and metronidazole in papulopustular rosacea
2006-001999-20Phase 2Completed
- Sponsor
- Galderma
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivermectin in papulopustular rosacea (6 arms), sponsored by Galderma. Started Jun 2006; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2006-001999-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001999-20.